Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Chalice Brands Ltd. CHALF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
13/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Chalice Brands Ltd. (CHALF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 12/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Net profit margin is 0% (thin). Gross margin is 30.8% (+17.5 pp trend).

Balance sheet: total debt is $11M against $5M equity (Debt-to-Equity (D/E) ratio 2.04, leveraged). Current ratio is 0.53 (tight liquidity). Debt-to-assets is 39.9%. Total assets: $28M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 0/100 (Fail), Health 0/100 (Fail), Moat 36/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

CHALF SharesGrow Score Overview

26/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 0/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 36/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — CHALF

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
15/100
CHALF: -21.7%/yr revenue is, -148.1%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
—
HEALTH N/A
N/A
No analyst coverage available for this stock.
✗
MOAT Fail
36/100
CHALF: Gross margin is 30.8% (+17.5 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 36/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range0.000001-0.0001
Volume209
Avg Volume (30D)315
Market Cap$6.66K
Beta (1Y)7.70
Share Statistics
Shares Outstanding$45.93M
IPO Date2016-02-18
Employees313
CEOJeffrey Yapp
Financial Highlights & Ratios
Total Cash$905.15K
Total Debt$11.17M
Net Debt$10.27M
Total Assets$28.02M
Analyst Forecast
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINCA15756R1047

Price Chart

Track all markets on TradingView
CHALF
Chalice Brands Ltd. ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.00 52WK RANGE 0.00

People Also View

GRUSF
GRUSF
Grown Rogue International Inc.
$0.32
+0.75%
 GDNSF
GDNSF
Goodness Growth Holdings, Inc.
$0.45
+0.00%
 DBCCF
DBCCF
Decibel Cannabis Company Inc.
$0.09
-4.33%
 CANSF
CANSF
Willow Biosciences Inc.
$0.11
+0.00%
 CXXIF
CXXIF
C21 Investments Inc.
$0.31
+15.12%
 CNTMF
CNTMF
Cansortium Inc.
$0.04
+0.19%
 RAMMF
RAMMF
RAMM Pharma Corp.
$0.06
+0.00%
 CLSH
CLSH
CLS Holdings USA, Inc.
$0.04
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message